Effectiveness of intramuscular ergocalciferol treatment in a patient with osteomalacia and insufficiency fractures due to severe vitamin D deficiency after bariatric surgery.
Bone Density Conservation Agents
/ administration & dosage
Delayed-Action Preparations
/ administration & dosage
Ergocalciferols
/ administration & dosage
Female
Fractures, Stress
/ etiology
Gastric Bypass
/ adverse effects
Humans
Injections, Intramuscular
Middle Aged
Obesity, Morbid
/ surgery
Osteomalacia
/ drug therapy
Vitamin D Deficiency
/ drug therapy
Bariatric Surgery
Ergocalciferol
Osteomalacia
Roux-en-Y Gastric By-pass
Vitamin D Deficiency
Journal
Journal of musculoskeletal & neuronal interactions
ISSN: 1108-7161
Titre abrégé: J Musculoskelet Neuronal Interact
Pays: Greece
ID NLM: 101084496
Informations de publication
Date de publication:
01 06 2020
01 06 2020
Historique:
entrez:
3
6
2020
pubmed:
3
6
2020
medline:
5
6
2021
Statut:
ppublish
Résumé
Vitamin D (vitD) deficiency and bone loss may occur after bariatric surgery and hence, supplementation with high oral doses of vitD may be required. Alternatively, intramuscular depot ergocalciferol, which slowly releases vitD and bypasses the gastrointestinal tract, could be administrated. We present a case of severe vitD deficiency-osteomalacia after gastric bypass operation for morbid obesity, treated with ergocalciferol intramuscularly. A 45-year-old woman was presented with hip pain and muscle weakness, which led ultimately to immobilization in a wheelchair. Fifteen years ago, she underwent roux-en-Y gastric by-pass for morbid obesity. Occasionally, she was treated with multivitamin supplements. On admission, iron deficiency anaemia, vitD deficiency (25OHD: 3.7 ng/ml) and secondary hyperparathyroidism were revealed. Bone turnover markers (BTM) were elevated. Radiological evaluation demonstrated insufficiency fractures on the pubic and left femur and reduced BMD. Osteomalacia due to vitD deficiency and calcium malabsorption were diagnosed. Calcium citrate 500 mg qid and intramuscular ergocalciferol 600,000 IU every 20 days were initiated. One month later, musculoskeletal pain and weakness were resolved and the patient was mobilized. Few months later, vitD, BTM and BMD showed substantial improvement. Intramuscular ergocalciferol administration can improve the clinical and biochemical status and thus, is suggested to prevent and/or treat osteomalacia in such patients.
Substances chimiques
Bone Density Conservation Agents
0
Delayed-Action Preparations
0
Ergocalciferols
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
291-296Déclaration de conflit d'intérêts
The authors have no conflict of interest.
Références
Osteoporos Int. 2018 Aug;29(8):1697-1711
pubmed: 29713796
Endocr Pract. 2004 May-Jun;10(3):195-8
pubmed: 15310536
Obes Surg. 2009 Sep;19(9):1256-61
pubmed: 19437082
Obes Surg. 2002 Oct;12(5):685-92
pubmed: 12448393
J Clin Endocrinol Metab. 2014 Sep;99(9):3373-81
pubmed: 24885631
Metabolism. 2016 Apr;65(4):574-85
pubmed: 26805016
J Musculoskelet Neuronal Interact. 2010 Dec;10(4):287-9
pubmed: 21116067
J Bone Miner Res. 2018 Jun;33(6):975-986
pubmed: 29281126
J Clin Endocrinol Metab. 2010 Nov;95(11):4823-43
pubmed: 21051578
Am J Med Sci. 2005 Feb;329(2):57-61
pubmed: 15711420
J Clin Endocrinol Metab. 2008 Aug;93(8):3015-20
pubmed: 18492750
Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):227-229
pubmed: 29263738
J Clin Pharmacol. 1999 Nov;39(11):1151-4
pubmed: 10579145
Endocr Pract. 2009 Sep-Oct;15(6):528-33
pubmed: 19491072
N Engl J Med. 1985 Jul 11;313(2):70-3
pubmed: 4000241
J Clin Endocrinol Metab. 2013 Jul;98(7):2709-15
pubmed: 23766519
Endocrinology. 2016 Sep;157(9):3384-7
pubmed: 27580803
Endocr Pract. 2013 Mar-Apr;19(2):337-72
pubmed: 23529351
Clin Drug Investig. 2011;31(5):285-98
pubmed: 21405146
BMJ. 2016 Jul 27;354:i3794
pubmed: 27814663
N Engl J Med. 2007 Aug 23;357(8):753-61
pubmed: 17715409
Gastroenterology. 2007 May;132(6):2253-71
pubmed: 17498516
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4104-4112
pubmed: 30219833
Nat Rev Endocrinol. 2012 Sep;8(9):544-56
pubmed: 22525731
J Bone Miner Res. 2015 Aug;30(8):1377-85
pubmed: 25640580
Obes Surg. 2017 Sep;27(9):2279-2289
pubmed: 28405878
Am J Clin Nutr. 2012 Jun;95(6):1357-64
pubmed: 22552031
J Endocr Soc. 2017 Jul 14;1(8):1079-1084
pubmed: 29264560